BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 31019654)

  • 1. Dihydrotanshinone-Induced NOX5 Activation Inhibits Breast Cancer Stem Cell through the ROS/Stat3 Signaling Pathway.
    Kim SL; Choi HS; Kim JH; Jeong DK; Kim KS; Lee DS
    Oxid Med Cell Longev; 2019; 2019():9296439. PubMed ID: 31019654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol derived from aronia juice through lactic acid bacteria fermentation inhibits breast cancer stem cell formation via modulation Stat3/IL-6 signaling pathway.
    Choi HS; Kim JH; Kim SL; Deng HY; Lee D; Kim CS; Yun BS; Lee DS
    Mol Carcinog; 2018 Nov; 57(11):1467-1479. PubMed ID: 29964299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway.
    Liu C; Dong L; Sun Z; Wang L; Wang Q; Li H; Zhang J; Wang X
    Phytother Res; 2018 Nov; 32(11):2299-2311. PubMed ID: 30080291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
    Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
    J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway.
    Nourbakhsh M; Farzaneh S; Taghikhani A; Zarghi A; Noori S
    Anticancer Agents Med Chem; 2020; 20(7):875-886. PubMed ID: 31893999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Desmethylsinensetin isolated from Artemisia princeps suppresses the stemness of breast cancer cells via Stat3/IL-6 and Stat3/YAP1 signaling.
    Liu R; Choi HS; Ko YC; Yun BS; Lee DS
    Life Sci; 2021 Sep; 280():119729. PubMed ID: 34146553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
    Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
    Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
    Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
    Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of the NF-κB/IL-8 Signaling Axis by Sulconazole Inhibits Human Breast Cancer Stem Cell Formation.
    Choi HS; Kim JH; Kim SL; Lee DS
    Cells; 2019 Aug; 8(9):. PubMed ID: 31480284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Betavulgarin Isolated from Sugar Beet (
    Liu R; Choi HS; Zhen X; Kim SL; Kim JH; Ko YC; Yun BS; Lee DS
    Molecules; 2020 Jun; 25(13):. PubMed ID: 32630026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells.
    Lin L; Hutzen B; Lee HF; Peng Z; Wang W; Zhao C; Lin HJ; Sun D; Li PK; Li C; Korkaya H; Wicha MS; Lin J
    PLoS One; 2013; 8(12):e82821. PubMed ID: 24376586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triterpene Acid (
    Choi HS; Kim SL; Kim JH; Deng HY; Yun BS; Lee DS
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of ovatodiolide, a macrocyclic diterpenoid, as a potential inhibitor of oral cancer stem-like cells properties via the inhibition of the JAK2/STAT3/JARID1B signal circuit.
    Lin CS; Bamodu OA; Kuo KT; Huang CM; Liu SC; Wang CH; Tzeng YM; Chao TY; Yeh CT
    Phytomedicine; 2018 Jul; 46():93-103. PubMed ID: 30097127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.
    Wei W; Tweardy DJ; Zhang M; Zhang X; Landua J; Petrovic I; Bu W; Roarty K; Hilsenbeck SG; Rosen JM; Lewis MT
    Stem Cells; 2014 Oct; 32(10):2571-82. PubMed ID: 24891218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of prostate tumor-initiating cells is associated with elevation of reactive oxygen species and IL-6/STAT3 signaling.
    Qu Y; Oyan AM; Liu R; Hua Y; Zhang J; Hovland R; Popa M; Liu X; Brokstad KA; Simon R; Molven A; Lin B; Zhang WD; McCormack E; Kalland KH; Ke XS
    Cancer Res; 2013 Dec; 73(23):7090-100. PubMed ID: 24101153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory Effects of Tangeretin, A Citrus Peel-Derived Flavonoid, on Breast Cancer Stem Cell Formation through Suppression of Stat3 Signaling.
    Ko YC; Choi HS; Liu R; Kim JH; Kim SL; Yun BS; Lee DS
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32503228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade.
    Zhang Z; Duan Q; Zhao H; Liu T; Wu H; Shen Q; Wang C; Yin T
    Cancer Lett; 2016 Nov; 382(1):53-63. PubMed ID: 27576197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 13
    Wang L; Choi HS; Lee B; Choi JH; Jang YS; Seo JW
    Antioxidants (Basel); 2021 Mar; 10(3):. PubMed ID: 33804152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1α and p27
    Antony S; Jiang G; Wu Y; Meitzler JL; Makhlouf HR; Haines DC; Butcher D; Hoon DS; Ji J; Zhang Y; Juhasz A; Lu J; Liu H; Dahan I; Konate M; Roy KK; Doroshow JH
    Mol Carcinog; 2017 Dec; 56(12):2643-2662. PubMed ID: 28762556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells.
    Li Y; Zhang T; Korkaya H; Liu S; Lee HF; Newman B; Yu Y; Clouthier SG; Schwartz SJ; Wicha MS; Sun D
    Clin Cancer Res; 2010 May; 16(9):2580-90. PubMed ID: 20388854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.